{"schema":"qazvision-content-revisions/v1","entity":{"type":"atom","code":"AKR-2026-0225-GLAVANAGRA-D-003","history_url":"https://qaz.vision/api/revisions/atom/AKR-2026-0225-GLAVANAGRA-D-003.json"},"verification":{"hash_algorithm":"sha256","chain":"previous_hash points to the preceding content_hash for this entity","payload_included":false},"revision_count":2,"limit":20,"current":{"id":16823,"entity_type":"atom","entity_id":4352,"entity_code":"AKR-2026-0225-GLAVANAGRA-D-003","revision_number":2,"operation":"baseline","public_state":"published","content_hash":"bf9ddbf1d75fbe516042f769a5cf377452520c0af7ada463d1678cc012254851","previous_hash":"d66e0bec68cb850850d5b1de8d1ccd805386ac51b32cd0f4168feffba190cece","created_at":"2026-07-14T05:09:33.045882Z","canonical_url":"https://qaz.vision/dokument/543"},"revisions":[{"id":16823,"entity_type":"atom","entity_id":4352,"entity_code":"AKR-2026-0225-GLAVANAGRA-D-003","revision_number":2,"operation":"baseline","public_state":"published","content_hash":"bf9ddbf1d75fbe516042f769a5cf377452520c0af7ada463d1678cc012254851","previous_hash":"d66e0bec68cb850850d5b1de8d1ccd805386ac51b32cd0f4168feffba190cece","created_at":"2026-07-14T05:09:33.045882Z","canonical_url":"https://qaz.vision/dokument/543"},{"id":6254,"entity_type":"atom","entity_id":4352,"entity_code":"AKR-2026-0225-GLAVANAGRA-D-003","revision_number":1,"operation":"baseline","public_state":"published","content_hash":"d66e0bec68cb850850d5b1de8d1ccd805386ac51b32cd0f4168feffba190cece","previous_hash":null,"created_at":"2026-07-13T18:08:49.497964Z","canonical_url":"https://qaz.vision/dokument/543"}]}